Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.
AIDS and Employment: Asymptomatic Human Immunodeficiency Virus Carriers and Section 504 of the Rehabilitation Act
AIDS & Public Policy Journal 5, no. 4 (Winter 1990): 167-72 Ronald Turner
In School Board of Nassau County, Florida v. Arline, the U.S. Supreme Court held that a school teacher with tuberculosis was a handicapped individual within the meaning of Section 504 of the Vocational Rehabilitation Act of 1973. Because the condition had required hospitalization, Arline had established that one or more of her major life activities was substantially limited by her impairment, thereby satisfying clause (i) of Section 706(8)(B). In addition, the Court found that the teacher's earlier hospitalization for tuberculosis sufficed to establish a record of impairment within the meaning of the Rehabilitation Act. The Arline Court made it clear that the case did "not present, and we therefore do not reach, the questions whether a carrier of a contagious disease such as AIDS could be considered to have a physical impairment, or whether such a person could be considered, solely on the basis of contagiousness, a handicapped person as defined by the Act. Thus, although the Court's analysis suggests that it would consider AIDS or AIDS-related complex (ARC) to be handicaps under the Act in certain circumstances, the Act's coverage of asymptomatic carriers of human immunodeficiency virus (HIV) remains an open and unresolved question, the significance of which is discussed below as it pertains to employment matters. In part I, I discuss the statutory and regulatory framework of the Act and its definitions of handicap, impairment, and major life activities. In part II, I offer a brief discussion of pertinent case law involving asymptomatic carriers. Part III contains a review of the opposite conclusions reached by Justice Department officials on the question of whether asymptomatic HIV carriers are protected by Section 504.
901215
APPJ905403
AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, Bridgestone/Firestone Charitable Trust, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.
